37.18
price down icon2.44%   -0.93
after-market After Hours: 37.18
loading

Vera Therapeutics Inc Stock (VERA) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
15.11%
31.11
27.03 21.76 21.97 31.26
Interest Income/Expense
80.49%
1.906
1.056 0.943 0.914 0.874
Operating Income/Loss
15.11%
-31.11
-27.03 -21.76 -21.97 -31.26
Nonoperating Income/Loss
98.62%
2.729
1.374 1.652 1.808 1.189
Income/Loss From Continuing Operations Before Tax
10.64%
-28.38
-25.65 -20.10 -20.16 -30.07
Income/Loss From Continuing Operations After Tax
10.63%
-28.38
-25.66 -20.10 -20.16 -30.07
Net Income/Loss
10.63%
-28.38
-25.66 -20.10 -20.16 -30.07
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
8,654%
50.97
0.5823 44.36 44.27 37.67
Diluted Average Shares
8,654%
50.97
0.5823 44.36 44.27 37.67
Basic Earnings Per Share
3.45%
-0.56
-0.58 -0.45 -0.46 -0.80
Diluted Earnings Per Share
3.45%
-0.56
-0.58 -0.45 -0.46 -0.80
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):